Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 02 Nov 2017 Planned End Date changed from 1 Sep 2018 to 1 Apr 2018.
- 02 Nov 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Apr 2018.
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.